A real portfolio and a marketing team too small for it.
Mid-size pharmaceutical laboratories carry the same regulatory complexity as a large company on a fraction of the internal digital resource: a handful of people responsible for corporate, product and often HCP content across several markets at once.
The defining constraint is not budget in the abstract, it is internal capacity. A two or three person marketing team cannot maintain the same platform sprawl a larger company’s dedicated digital function can, which shapes every recommendation toward what that team can actually sustain.
Platforms built for a small team to run independently, content prioritised by what actually drives the business rather than completeness for its own sake, and a relationship that scales support up or down with real need.
Our platforms and ongoing support are built to make a lean in-house team perform like a larger one — you keep control, we cover what your headcount alone can’t.
The scope our work with mid-size pharma companies has operated within.
The build priorities for a small, capable team differ from a large one. Here is what mid-size pharma teams most often need.
How this work is approached specifically for Mid-Size Pharma.
What comes up when working with a smaller pharmaceutical team.
No — we scope projects to match what matters for a company your size, which typically means a tighter budget spent on the pages and functionality your buyers use most, rather than the full enterprise feature set a multinational might commission. Most mid-size pharma engagements we run cost a fraction of what a global affiliate rollout requires, without cutting the parts that drive real inquiries.
Yes — that is the specific outcome we design toward for this segment, not an afterthought. We build with a content structure a marketing manager can update without a developer, templated components for new products or trial sites, and documentation written for someone without a technical background. See marketing team autonomy for how that structure holds up once the site is live and growing.
The platform is built to extend rather than be replaced as you grow, since a rebuild every time headcount or product count increases is the outcome we are specifically avoiding. New product lines, additional markets, or a move into e-commerce can typically be added as modules onto the existing structure, and our support relationship scales alongside the team rather than requiring a new vendor search.
Yes — mid-size pharmaceutical and laboratory companies make up one of our most common client profiles, not an edge case we occasionally accommodate. That volume of experience means the approach reflects real patterns from this segment specifically — limited internal marketing headcount, a need to look credible against much larger competitors, and budgets that require every page to earn its cost — rather than a scaled-down enterprise playbook.
Related sectors worth reviewing alongside mid-size pharma.
A team that needs more than its headcount would suggest is possible. Tell us your situation and we will tell you how we would approach it for a mid-size pharma company.